| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ocaperidone | alpha-1a adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| ocaperidone | alpha-1b adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| ocaperidone | alpha-1d adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| ocaperidone | alpha-2a adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| ocaperidone | alpha-2b adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| ocaperidone | alpha-2c adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| ocaperidone | connective tissue growth factor | NA | Clinical trial target | TTD | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | phase 2 | unknown |
| ocaperidone | dopamine d2 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
0.12 | investigational,phase 2 | unknown |
| ocaperidone | histamine h1 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| ocaperidone | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
0.15 | phase 2 | unknown |
| ocaperidone | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
0.15 | investigational | unknown |
| ocaperidone | 5-hydroxytryptamine receptor 2b | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| ocaperidone | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Pancreatic carcinoma[MeSHID:C562463] Hamman-Rich syndrome[MeSHID:D011658] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Diabetic Nephropathy[MeSHID:D003928] |
NA | investigational | unknown |
| click here to return to the previous page | ||||||||